Novonesis (Novozymes) B's quarterly market cap
increased
from Sep. 2025 ($28,467 Mil) to Dec. 2025 ($29,641 Mil) but then
declined
from Dec. 2025 ($29,641 Mil) to Mar. 2026 ($27,864 Mil).
Novonesis (Novozymes) B's annual market cap
increased
from Dec. 2023 ($15,226 Mil) to Dec. 2024 ($26,355 Mil) and
increased
from Dec. 2024 ($26,355 Mil) to Dec. 2025 ($29,641 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Novonesis (Novozymes) B's Enterprise Value for Today is $32,912 Mil.
Novonesis (Novozymes) B (OTCPK:NVZMY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Novonesis (Novozymes) B Market Cap Related Terms
Novonesis (Novozymes) B Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novonesis (Novozymes) B Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Market Cap distribution charts can be found below:
* The bar in red indicates where Novonesis (Novozymes) B's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Novonesis (Novozymes) B's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B (NVZMY) has a Market Cap of $29,615 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Novonesis (Novozymes) B and its competitors. According to the industry distribution chart, Novonesis (Novozymes) B ranks #13 out of 1630 companies in the Chemicals industry, placing it in the top 0.8%.
Is Novonesis (Novozymes) B's Market Cap too high?
Novonesis (Novozymes) B's current Market Cap is $29,615 Mil. The Chemicals industry median Market Cap is 297.12. Novonesis (Novozymes) B's value of $29,615 Mil is 9867.5% above this industry median. Based on the distribution chart, Novonesis (Novozymes) B ranks #13 out of 1630 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Novonesis (Novozymes) B has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Market Cap compare to LIN and SHW?
According to the Chemicals industry distribution chart, Novonesis (Novozymes) B ranks #13 out of 1630 companies for Market Cap. This places Novonesis (Novozymes) B in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 297.12. Novonesis (Novozymes) B's value of $29,615 Mil is 9867.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 297.12, based on 1,630 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novonesis (Novozymes) B's current Market Cap of $29,615 Mil is 9867.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Novonesis (Novozymes) B and its competitors. For the Chemicals industry, the median Market Cap is 297.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novonesis (Novozymes) B's current Market Cap is $29,615 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Based on GuruFocus' analysis, Novonesis (Novozymes) B (NVZMY) is currently considered Fairly Valued. The stock's GF Value™ is $64.28, compared to a current price of $63.52 — trading 1.2% below its estimated fair value. The current Market Cap is $29,615 Mil and 9867.5% above the Chemicals industry median of 297.12. Novonesis (Novozymes) B's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Novonesis (Novozymes) B (NVZMY), the current Market Cap is $29,615 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novonesis (Novozymes) B (NVZMY) Overvalued in 2026?
Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued.
The current stock price of $63.52 is trading 1.2% below its estimated GF Value™ of $64.28.
GuruFocus considers Novonesis (Novozymes) B to be Fairly Valued.
Key valuation signals for NVZMY:
Market Cap: $29,615 Mil
GF Value™: $64.28 vs. price of $63.52 (1.2% below fair value)
Industry Position: 9867.5% above the Chemicals median (#13 of 1630)
No single metric tells the full story. See the NVZMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
88GF Score
Get the complete analysis for NVZMY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVZMY has been successfully added to your 
